Intervention Protocol

You have free access to this content

Interventions for maintenance of mucosal healing in ulcerative colitis

  1. Michael J Stewart1,
  2. Matthew Kutcher2,
  3. Martin Storr3,
  4. Cynthia H Seow4,*

Editorial Group: Cochrane IBD Group

Published Online: 20 FEB 2014

DOI: 10.1002/14651858.CD010998


How to Cite

Stewart MJ, Kutcher M, Storr M, Seow CH. Interventions for maintenance of mucosal healing in ulcerative colitis (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010998. DOI: 10.1002/14651858.CD010998.

Author Information

  1. 1

    Cedars-Sinai Medical Center, Inflammatory Bowel Disease Center, Los Angeles, California, USA

  2. 2

    Dalhousie University, Faculty of Medicine, Halifax, Nova Scotia, Canada

  3. 3

    University of Munich, Department of Medicine, Munich, Germany

  4. 4

    University of Calgary, Departments of Medicine & Community Health Sciences, Calgary, Alberta, Canada

*Cynthia H Seow, Departments of Medicine & Community Health Sciences, University of Calgary, TRW Building Rm 6D18, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. cseow@ucalgary.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 20 FEB 2014

SEARCH

References

Additional references

Ananthakrishnan 2012
Armuzzi 2012
  • Armuzzi A, Van Assche G, Reinisch W, Pineton de Chambrun G, Griffiths A, Sladek M, et al. Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease. Journal of Crohn's and Colitis 2012;6(4):492-502.
Baert 2010
  • Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138(2):463-8; quiz e10-1.
Baron 1964
Caprilli 2007
Colombel 2012
  • Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2012;141(4):1194-201.
Cronstein 1993
  • Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. Journal of Clinical Investigation 1993;92(6):2675-82.
Egger 1997
Feagan 2005
  • Feagan BG, Greenberg GR, Wild G, Fedorak RN, Pare P, McDonald JW, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. New England Journal of Medicine 2005;352(24):2499-507.
Froslie 2007
Gerner 2013
  • Gerner RR, Moschen AR, Tilg H. Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials. Digestive Diseases 2013;31(3-4):328-35.
Gupta 2007
  • Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133(4):1099-105; quiz 1340-1.
Guyatt 2008
  • Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
Higgins 2002
Higgins 2011a
  • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Langholz 1994
Lemann 1995
MacDermott 2000
  • MacDermott RP. Progress in understanding the mechanisms of action of 5-aminosalicylic acid. American Journal of Gastroenterology 2000;95(12):3343-5.
    Direct Link:
Moher 2009
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9, W64.
Powell-Tuck 1982
  • Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Digestive Diseases and Sciences 1982;27(6):533-7.
Rachmilewitz 1989
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rubin 1999
  • Rubin RH, Ikonen T, Gummert JF, Morris RE. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transplant Infectious Disease 1999;1(1):29-39.
Rutter 2004a
  • Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126(2):451-9.
Rutter 2004b
  • Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004;53(12):1813-6.
Sahasranaman 2008
Schroeder 1987
  • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. New England Journal of Medicine 1987;317(26):1625-9.
Schünemann 2011
  • Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Sutherland 1987
  • Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987;92(6):1894-8.
Travis 2012
  • Travis SP, Schnell D, Krzeski P, Abreu MT, Altman DG, Colombel JF, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012;61(4):535-42.
Truelove 1955
Van den Brande 2003
  • Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003;124(7):1774-85.